A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group (Q72909489)
Jump to navigation
Jump to search
scientific article published on 01 June 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group |
scientific article published on 01 June 1993 |
Statements
A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group (English)
S A Montgomery
A McIntyre
M Osterheider
P Sarteschi
W Zitterl
J Zohar
M Birkett